| [1] |
Charlton RA,Lamar M,Zhang A, et al. White-matter tract integrity in late-life depression: associations with severity and cognition[J].Psychol Med, 2014, 44(7):1427-1437.
|
| [2] |
Mitchell AJ,Rao S,Vaze A. Do primary care physicians have particular difficulty identifying late-life depression? A meta-analysis stratified by age[J]. Psychother Psychosom, 2010, 79(5):285-294.
|
| [3] |
Hickie IB,Naismith SL,Ward PB, et al. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression[J]. J Afferct Disord, 2007, 98(1-2):137-142.
|
| [4] |
Alexopoulos GS,Murphy CF,Gunningdixon FM, et al. Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression[J]. J Afferct Disord, 2009, 119(3):132-141.
|
| [5] |
Taylor WD,Steffens DC,Payne ME, et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression[J]. Arch Gen Psychiatry, 2005, 62(5):537.
|
| [6] |
Duman RS,Monteggia LM. A neurotrophic model for stress-related mood disorders[J]. Biol Psychiatry, 2006, 59(12):1116-1127.
|
| [7] |
Berton O,Mcclung CA,Dileone RJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress[J]. Science, 2006, 311(5762):864-868.
|
| [8] |
Pei Y,Smith AK,Wang Y, et al. The brain-derivedneurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis[J]. Am J Med Genet B Neuropsychiatr Genet, 2012, 159B(5):560-566.
|
| [9] |
Kanellopoulos D,Gunning FM,Morimoto SS, et al. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression[J]. Am J Geriatr Psychiatry, 2011, 19(1):13-22.
|
| [10] |
Taylor WD,Züchner S,Mcquoid DR, et al. Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression[J]. Am J Geriatr Psychiatry, 2007, 15(10):850-857.
|
| [11] |
Kang HJ,Bae KY,Kim SW, et al. Longitudinal associations between glucocorticoid receptor methylation and late-life depression[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2018, 84(Pt A):56-62.
|
| [12] |
Andreescu C,Butters MA,Begley A, et al. Gray matterchanges in late life depression-a structural MRI analysis[J]. Neuropsychopharmacology, 2008, 33(11):2566.
|
| [13] |
Sexton CE,Allan CL,Le MM, et al. Magnetic resonance imaging in late-life depression: multimodal examination of network disruption[J]. Arch Gen Psychiatry, 2012, 69(7):680-689.
|
| [14] |
Smagula SF,Aizenstein HJ. Brain structural connectivity in late-life major depressive disorder[J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2016, 1(3):271-277.
|
| [15] |
Du M,Liu J,Chen Z, et al. Brain grey matter volume alterations in late-life depression[J]. J Psychiatry Neurosci, 2014, 39(6):397.
|
| [16] |
Charlton RA,Leow A,Gadelkarim J, et al. Brain connectivity in late-life depression and aging revealed by network analysis[J]. Am J Geriatr Psychiatry, 2015, 23(6):642.
|
| [17] |
Reppermund S,Zhuang L,Wen W, et al. White matter integrity and late-life depression in community-dwelling individuals: diffusion tensor imaging study using tract-based spatial statistics[J]. Br J Psychiatry, 2011, 205(4):315-320.
|
| [18] |
Guo W,Liu F,Xun G, et al. Disrupted white matter integrity in first-episode, drug-naive, late-onset depression[J]. J Affect Disord, 2014, 163(9):70-75.
|
| [19] |
Sin ELL,Liu HL,Lee SH, et al. The relationships between brain structural changes and perceived loneliness in older adults suffering from late‐life depression[J]. Int J Geriatr Psychiatry, 2018, 33(4):606-612.
|
| [20] |
Dubois B,Defontaines B,Deweer B, et al. Cognitive and behavioral changes in patients with focal lesions of the basal ganglia[J]. Adv Neurol, 1995, 65:29-41.
|
| [21] |
Bae JN,Macfall JR,Krishnan KR, et al. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression[J]. Bio Psychiatry, 2006, 60(12):1356-1363.
|
| [22] |
Disabato BM,Morris C,Hranilovich J, et al. Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression[J]. Am J Geriatr Psychiatry, 2013, 22(10):1039-1046.
|
| [23] |
Delaloye C,Moy G,De BF, et al. Neuroanatomical andneuropsychological features of elderly euthymic depressed patients with early-and late-onset[J]. J Neurol Sci, 2010, 299(1):19-23.
|
| [24] |
Andreescu C,Butters MA,Begley A, et al. Gray matterchanges in late life depression-a structural MRI analysis[J]. Neuropsychopharmacology, 2007, 33(11):2566.
|
| [25] |
Ballmaier M,Narr KL,Toga AW, et al. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression[J]. Am J Psychiatry, 2008, 165(2):229-237.
|
| [26] |
Scott R,Paulson D. Cerebrovascular burden and depressive symptomatologyinterrelate over 18 years: support for the vascular depression hypothesis[J]. Int J Geriatr Psychiatry, 2017, 33(1):66-74.
|
| [27] |
Alexopoulos GS,Meyers S,Young RC, et al. 'Vascular depression' hypothesis[J]. Arch Gen Psychiatry, 1997, 54(10):915-922.
|
| [28] |
Greenstein AS,Paranthaman RA,Jackson A, et al. Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries[J]. Hypertension, 2010, 56(4):734.
|
| [29] |
Paranthaman R,Greenstein AS,Burns AS, et al. Vascular function in older adults with depressive disorder[J]. Bio Psychiatry, 2010, 68(2):133-139.
|
| [30] |
Tiemeier H,Breteler MM,van Popele NM, et al. Late-life depression is associated with arterial stiffness: a population-based study.[J]. J Am Geriatri Soc, 2010, 51(8):1105-1110.
|
| [31] |
Debiec J,Ledoux JE,Nader K. Cellular and systems reconsolidation in the hippocampus[J]. Neuron, 2002, 36(3):527-538.
|
| [32] |
Vardi N,Freedman N,Lester H, et al. Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implications[J]. Psychiatry Res, 2011, 192(2):125-130.
|
| [33] |
Alexopoulos GS. Frontostriatal and limbic dysfunction in late-life depression[J]. Am J Geriatr Psychiatry, 2002, 10(6):687-695.
|
| [34] |
Maes M,Leonard BE,Myint AM, et al. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35(3):702-721.
|
| [35] |
Miller AH. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface[J].Brain Behav Immun, 2009, 23(2):149-158.
|
| [36] |
Tsao CW,Lin YS,Chen CC, et al. Cytokines and serotonin transporter in patients with major depression[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2006, 30(5):899-905.
|
| [37] |
Koo JW,Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress[J]. Proc Natl Acad Sci USA, 2008, 105(2):751-756.
|
| [38] |
Slavich GM,Way BM,Eisenberger NI, et al. Neural sensitivity to social rejection is associated with inflammatory responses to social stress[J]. Proc Natl Acad Sci USA, 2010, 107(33):14817-14822.
|
| [39] |
Harrison NA,Brydon L,Walker C, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity[J]. Bio Psychiatry, 2009, 66(5):407-414.
|
| [40] |
Elderkin-Thompson V,Irwin MR,Hellemann G, et al. Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults[J]. Am J Geriatr Psychiatry, 2012, 20(9):753-763.
|
| [41] |
Satizabal CL,Zhu YC,Mazoyer B, et al. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study[J]. Neurology, 2012, 78(10):720-727.
|
| [42] |
Rhebergen D,Korten NC,Penninx BW, et al. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder[J]. Psychoneuroendocrinology, 2015, 51:341-350.
|
| [43] |
Belvederi MM,Pariante C,Mondelli V, et al. HPA axis and aging in depression: systematic review and meta-analysis[J]. Psychoneuroendocrinology, 2014, 41(1):46-62.
|
| [44] |
Bahls SC,de Carvalho GA. [The relation between thyroid function and depression: a review][J]. Rev Bras Psiquiatr, 2004, 26(1):41-49.
|
| [45] |
Chueire VB,Romaldini JH,Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly[J]. Arc Gerontol Geriatri, 2007, 44(1):21-28.
|
| [46] |
Jr MG,Kremer C,Rodrigues HE, et al. Pharmacogenetics of antidepressant medication intolerance[J]. Am J Psychiatry, 2003, 160(10):1830-1835.
|
| [47] |
Sanacora G,Zarate CA,Krystal JH, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders[J]. Nat Rev Drug Discov, 2008, 7(5):426-437.
|
| [48] |
Sanacora G,Mason GF,Rothman DL, et al. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors[J]. Am J Psychiatry, 2002, 159(4):663-665.
|
| [49] |
Silver AA,Shytle RD,Sheehan KH, et al. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder[J]. J Am Acad Child Adolesc Psychiatry, 2001, 40(9):1103-1110.
|
| [50] |
Mathew SJ,Manji HK,Charney DS. Novel drugs and therapeutic targets for severe mood disorders[J]. Neuropsychopharmacology, 2008, 33(9):2080-2092.
|
| [51] |
Lanni C,Govoni S,Lucchelli A, et al. Depression and antidepressants: molecular and cellular aspects[J]. Cell Mol Life Sci, 2009, 66(18):2985-3008.
|
| [52] |
Herpfer I,Lieb K. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential[J].CNS Drugs, 2005, 19(4):275-293.
|